Dipeptidyl peptidase-4

Mammalian protein found in humans
DPP4
Available structures
PDBOrtholog search: PDBe RCSB
List of PDB id codes

1J2E, 1N1M, 1NU6, 1NU8, 1PFQ, 1R9M, 1R9N, 1RWQ, 1TK3, 1TKR, 1U8E, 1W1I, 1WCY, 1X70, 2AJL, 2BGN, 2BGR, 2BUB, 2FJP, 2G5P, 2G5T, 2G63, 2HHA, 2I03, 2I78, 2IIT, 2IIV, 2JID, 2OAG, 2OGZ, 2OLE, 2ONC, 2OPH, 2OQI, 2OQV, 2P8S, 2QJR, 2QKY, 2QOE, 2QT9, 2QTB, 2RGU, 2RIP, 3BJM, 3C43, 3C45, 3CCB, 3CCC, 3D4L, 3EIO, 3F8S, 3G0B, 3G0C, 3G0D, 3G0G, 3H0C, 3HAB, 3HAC, 3KWF, 3KWJ, 3NOX, 3O95, 3O9V, 3OC0, 3OPM, 3Q0T, 3Q8W, 3QBJ, 3SWW, 3SX4, 3VJK, 3VJL, 3VJM, 3W2T, 4A5S, 4DSA, 4DSZ, 4DTC, 4G1F, 4JH0, 4KR0, 4L72, 4LKO, 4J3J, 4N8D, 4N8E, 4PNZ, 4PV7, 4QZV, 3WQH, 5KBY, 5ISM, 5I7U

Identifiers
AliasesDPP4, ADABP, ADCP2, CD26, DPPIV, TP103, dipeptidyl peptidase 4
External IDsOMIM: 102720 MGI: 94919 HomoloGene: 3279 GeneCards: DPP4
Gene location (Human)
Chromosome 2 (human)
Chr.Chromosome 2 (human)[1]
Chromosome 2 (human)
Genomic location for DPP4
Genomic location for DPP4
Band2q24.2Start161,992,245 bp[1]
End162,074,215 bp[1]
Gene location (Mouse)
Chromosome 2 (mouse)
Chr.Chromosome 2 (mouse)[2]
Chromosome 2 (mouse)
Genomic location for DPP4
Genomic location for DPP4
Band2 C1.3|2 35.85 cMStart62,160,417 bp[2]
End62,242,575 bp[2]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • Achilles tendon

  • jejunal mucosa

  • parotid gland

  • duodenum

  • kidney tubule

  • placenta

  • stromal cell of endometrium

  • parietal pleura

  • seminal vesicula

  • glomerulus
Top expressed in
  • jejunum

  • seminal vesicula

  • saccule

  • ileum

  • lacrimal gland

  • parotid gland

  • left lobe of liver

  • renal corpuscle

  • intestinal epithelium

  • intestinal villus
More reference expression data
BioGPS




More reference expression data
Gene ontology
Molecular function
  • dipeptidyl-peptidase activity
  • signaling receptor binding
  • identical protein binding
  • peptidase activity
  • hydrolase activity
  • virus receptor activity
  • protein homodimerization activity
  • serine-type peptidase activity
  • protease binding
  • aminopeptidase activity
  • protein binding
  • serine-type endopeptidase activity
Cellular component
  • lamellipodium membrane
  • extracellular exosome
  • lysosomal membrane
  • endocytic vesicle
  • integral component of membrane
  • cell projection
  • cell junction
  • lamellipodium
  • apical plasma membrane
  • membrane
  • focal adhesion
  • cell surface
  • intercellular canaliculus
  • membrane raft
  • extracellular region
  • plasma membrane
Biological process
  • response to hypoxia
  • T cell costimulation
  • psychomotor behavior
  • behavioral fear response
  • negative regulation of extracellular matrix disassembly
  • regulation of cell-cell adhesion mediated by integrin
  • locomotory exploration behavior
  • endothelial cell migration
  • positive regulation of cell population proliferation
  • T cell activation
  • cell adhesion
  • viral entry into host cell
  • regulation of insulin secretion
  • proteolysis
Sources:Amigo / QuickGO
Orthologs
SpeciesHumanMouse
Entrez

1803

13482

Ensembl

ENSG00000197635

ENSMUSG00000035000

UniProt

P27487

P28843

RefSeq (mRNA)

NM_001935

NM_001159543
NM_010074

RefSeq (protein)

NP_001926
NP_001366533
NP_001366534
NP_001366535

NP_001153015
NP_034204

Location (UCSC)Chr 2: 161.99 – 162.07 MbChr 2: 62.16 – 62.24 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Dipeptidyl peptidase-4 (DPP4 or DPPIV), also known as adenosine deaminase complexing protein 2 or CD26 (cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene.[5] DPP4 is related to FAP, DPP8, and DPP9. The enzyme was discovered in 1966 by Hopsu-Havu and Glenner,[6] and as a result of various studies on chemism, was called dipeptidyl peptidase IV [DP IV].

Function

The protein encoded by the DPP4 gene is an enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction, and apoptosis. It is a type II transmembrane glycoprotein, but a soluble form, which lacks the intracellular and transmembrane part, is present in blood plasma and various body fluids. DPP-4 is a serine exopeptidase that cleaves X-proline or X-alanine dipeptides from the N-terminus of polypeptides. Peptide bonds involving the cyclic amino acid proline cannot be cleaved by the majority of proteases and an N-terminal X-proline "shields" various biopeptides.[7] Extracellular proline-specific proteases therefore play an important role in the regulation of these biopeptides.

DPP-4 is known to cleave a broad range of substrates including growth factors, chemokines, neuropeptides, and vasoactive peptides.[8][9] The cleaved substrates lose their biological activity in the majority of cases, but in the case of the chemokine RANTES and neuropeptide Y, DPP-4 mediated cleavage leads to a shift in the receptor subtype binding.[8]

DPP4 plays a major role in glucose metabolism. It is responsible for the degradation of incretins such as GLP-1.[10] Furthermore, it appears to work as a suppressor in the development of some tumors.[11][12][13][14]

DPP-4 also binds the enzyme adenosine deaminase specifically and with high affinity. The significance of this interaction has yet to be established.

Animal studies

Animal studies suggest its pathogenetic role in development of fibrosis of various organs, such as liver and kidney.[15][16]

Clinical significance

CD26/DPPIV plays an important role in tumor biology, and is useful as a marker for various cancers, with its levels either on the cell surface or in the serum increased in some neoplasms and decreased in others.[17]

A class of oral hypoglycemics called dipeptidyl peptidase-4 inhibitors works by inhibiting the action of this enzyme, thereby prolonging incretin effect in vivo.[18]

Middle East respiratory syndrome coronavirus has been found to bind to DPP4. It is found on the surface of cells in the airways (such as the lungs) and kidneys. Scientists may be able to use this to their advantage by blocking the virus's entry into the cell.[19]

DPP4,[20] or its Mycobacterial homologue MtDPP,[21] might play a role in the pathogenesis of tuberculosis via cleavage of the chemokine C-X-C motif chemokine ligand 10 (CXCL10).

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000197635 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000035000 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C (July 1993). "Direct association of adenosine deaminase with a T cell activation antigen, CD26". Science. 261 (5120): 466–9. Bibcode:1993Sci...261..466K. doi:10.1126/science.8101391. PMID 8101391.
  6. ^ Hopsu-Havu VK, Glenner GG (1966). "A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide". Histochemie. Histochemistry. Histochimie. 7 (3): 197–201. doi:10.1007/bf00577838. PMID 5959122. S2CID 9674831.
  7. ^ Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpé S (June 1995). "Proline motifs in peptides and their biological processing". FASEB Journal. 9 (9): 736–44. doi:10.1096/fasebj.9.9.7601338. PMID 7601338. S2CID 37551773.
  8. ^ a b Mentlein R (November 1999). "Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides". Regulatory Peptides. 85 (1): 9–24. doi:10.1016/S0167-0115(99)00089-0. PMID 10588446. S2CID 22354304.
  9. ^ Chen X (2006). "Biochemical properties of recombinant prolyl dipeptidases DPP-IV and DPP8". Dipeptidyl Aminopeptidases. Advances in Experimental Medicine and Biology. Vol. 575. pp. 27–32. doi:10.1007/0-387-32824-6_3. ISBN 978-0-387-29058-4. PMID 16700505.
  10. ^ Barnett A (November 2006). "DPP-4 inhibitors and their potential role in the management of type 2 diabetes". International Journal of Clinical Practice. 60 (11): 1454–70. doi:10.1111/j.1742-1241.2006.01178.x. PMID 17073841. S2CID 2645092.
  11. ^ Pro B, Dang NH (October 2004). "CD26/dipeptidyl peptidase IV and its role in cancer". Histology and Histopathology. 19 (4): 1345–51. doi:10.14670/HH-19.1345. PMID 15375776.
  12. ^ Masur K, Schwartz F, Entschladen F, Niggemann B, Zaenker KS (December 2006). "DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells". Regulatory Peptides. 137 (3): 147–55. doi:10.1016/j.regpep.2006.07.003. PMID 16908079. S2CID 2857735.
  13. ^ Wesley UV, McGroarty M, Homoyouni A (February 2005). "Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway". Cancer Research. 65 (4): 1325–34. doi:10.1158/0008-5472.CAN-04-1852. PMID 15735018.
  14. ^ Busek P, Malík R, Sedo A (March 2004). "Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer". The International Journal of Biochemistry & Cell Biology. 36 (3): 408–21. doi:10.1016/S1357-2725(03)00262-0. PMID 14687920.
  15. ^ Kaji K, Yoshiji H, Ikenaka Y, Noguchi R, Aihara Y, Douhara A, Moriya K, Kawaratani H, Shirai Y, Yoshii J, Yanase K, Kitade M, Namisaki T, Fukui H (March 2014). "Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats". Journal of Gastroenterology. 49 (3): 481–91. doi:10.1007/s00535-013-0783-4. PMID 23475323. S2CID 2726091.
  16. ^ Min HS, Kim JE, Lee MH, Song HK, Kang YS, Lee MJ, Lee JE, Kim HW, Cha JJ, Chung YY, Hyun YY, Han JY, Cha DR (June 2014). "Dipeptidyl peptidase IV inhibitor protects against renal interstitial fibrosis in a mouse model of ureteral obstruction". Laboratory Investigation; A Journal of Technical Methods and Pathology. 94 (6): 598–607. doi:10.1038/labinvest.2014.50. PMID 24687121. S2CID 23745972.
  17. ^ Havre PA, Abe M, Urasaki Y, Ohnuma K, Morimoto C, Dang NH (January 2008). "The role of CD26/dipeptidyl peptidase IV in cancer". Frontiers in Bioscience. 13 (13): 1634–45. doi:10.2741/2787. PMID 17981655.
  18. ^ Rosenstock J, Zinman B (April 2007). "Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus". Current Opinion in Endocrinology, Diabetes and Obesity. 14 (2): 98–107. doi:10.1097/MED.0b013e3280a02f65. PMID 17940427. S2CID 25482131.
  19. ^ Raj VS, Mou H, Smits SL, Dekkers DH, Müller MA, Dijkman R, Muth D, Demmers JA, Zaki A, Fouchier RA, Thiel V, Drosten C, Rottier PJ, Osterhaus AD, Bosch BJ, Haagmans BL (March 2013). "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC". Nature. 495 (7440): 251–4. Bibcode:2013Natur.495..251R. doi:10.1038/nature12005. PMC 7095326. PMID 23486063.
    • Tina Hesman Saey (March 13, 2013). "News in Brief: New virus uses protein handle to infect cells". ScienceNews. Archived from the original on 2013-03-20.
  20. ^ Blauenfeldt T, Petrone L, Del Nonno F, Baiocchini A, Falasca L, Chiacchio T, Bondet V, Vanini V, Palmieri F, Galluccio G, Casrouge A, Eugen-Olsen J, Albert ML, Goletti D, Duffy D, Ruhwald M (Jul 2018). "Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions". Front Immunol. 9 (1456): 1456. doi:10.3389/fimmu.2018.01456. PMC 6041415. PMID 30026741.
  21. ^ Lioe TS, Xie Z, Wu J, Li W, Sun L, Feng Q, Raju S, Tefsen B, Ruiz-Carrillo D (Jan 2023). "The Mycobacterium tuberculosis prolyl dipeptidyl peptidase cleaves the N-terminal peptide of the immunoprotein CXCL-10". Biol Chem. 404 (6): 633–43. doi:10.1515/hsz-2022-0265. PMID 36632703. S2CID 255596512.

Further reading

  • Ansorge S, Bühling F, Kähne T, Lendeckel U, Reinhold D, Täger M, Wrenger S (1997). "CD26/Dipeptidyl Peptidase IV in Lymphocyte Growth Regulation". Cellular Peptidases in Immune Functions and Diseases. Advances in Experimental Medicine and Biology. Vol. 421. pp. 127–40. doi:10.1007/978-1-4757-9613-1_17. ISBN 978-1-4757-9615-5. PMID 9330689.
  • Reinhold D, Kähne T, Steinbrecher A, Wrenger S, Neubert K, Ansorge S, Brocke S (2003). "The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity". Biological Chemistry. 383 (7–8): 1133–8. doi:10.1515/BC.2002.123. PMID 12437097. S2CID 30027839.
  • Sato K, Dang NH (March 2003). "CD26: a novel treatment target for T-cell lymphoid malignancies? (Review)". International Journal of Oncology. 22 (3): 481–97. doi:10.3892/ijo.22.3.481 (inactive 31 January 2024). PMID 12579300.{{cite journal}}: CS1 maint: DOI inactive as of January 2024 (link)
  • de Meester I, Lambeir AM, Proost P, Scharpé S (2003). "Dipeptidyl Peptidase IV Substrates". Dipeptidyl Aminopeptidases in Health and Disease. Advances in Experimental Medicine and Biology. Vol. 524. pp. 3–17. doi:10.1007/0-306-47920-6_1. ISBN 0-306-47717-3. PMID 12675218.
  • Koch S, Anthonsen D, Skovbjerg H, Sjöström H (2003). "On the role of dipeptidyl peptidase IV in the digestion of an immunodominant epitope in celiac disease". Dipeptidyl Aminopeptidases in Health and Disease. Advances in Experimental Medicine and Biology. Vol. 524. pp. 181–7. doi:10.1007/0-306-47920-6_22. ISBN 0-306-47717-3. PMID 12675238.
  • Pro B, Dang NH (October 2004). "CD26/dipeptidyl peptidase IV and its role in cancer". Histology and Histopathology. 19 (4): 1345–51. doi:10.14670/HH-19.1345. PMID 15375776.

External links

  • v
  • t
  • e
  • 1j2e: Crystal structure of Human Dipeptidyl peptidase IV
    1j2e: Crystal structure of Human Dipeptidyl peptidase IV
  • 1n1m: Human Dipeptidyl Peptidase IV/CD26 in complex with an inhibitor
    1n1m: Human Dipeptidyl Peptidase IV/CD26 in complex with an inhibitor
  • 1nu6: Crystal structure of human Dipeptidyl Peptidase IV (DPP-IV)
    1nu6: Crystal structure of human Dipeptidyl Peptidase IV (DPP-IV)
  • 1nu8: Crystal structure of human dipeptidyl peptidase IV (DPP-IV) in complex with Diprotin A (ILI)
    1nu8: Crystal structure of human dipeptidyl peptidase IV (DPP-IV) in complex with Diprotin A (ILI)
  • 1pfq: crystal structure of human apo dipeptidyl peptidase IV / CD26
    1pfq: crystal structure of human apo dipeptidyl peptidase IV / CD26
  • 1r9m: Crystal Structure of Human Dipeptidyl Peptidase IV at 2.1 Ang. Resolution.
    1r9m: Crystal Structure of Human Dipeptidyl Peptidase IV at 2.1 Ang. Resolution.
  • 1r9n: Crystal Structure of human dipeptidyl peptidase IV in complex with a decapeptide (tNPY) at 2.3 Ang. Resolution
    1r9n: Crystal Structure of human dipeptidyl peptidase IV in complex with a decapeptide (tNPY) at 2.3 Ang. Resolution
  • 1rwq: Human Dipeptidyl peptidase IV in complex with 5-aminomethyl-6-(2,4-dichloro-phenyl)-2-(3,5-dimethoxy-phenyl)-pyrimidin-4-ylamine
    1rwq: Human Dipeptidyl peptidase IV in complex with 5-aminomethyl-6-(2,4-dichloro-phenyl)-2-(3,5-dimethoxy-phenyl)-pyrimidin-4-ylamine
  • 1tk3: Crystal Structure Of Human Apo Dipeptidyl Peptidase IV/CD26
    1tk3: Crystal Structure Of Human Apo Dipeptidyl Peptidase IV/CD26
  • 1tkr: Human Dipeptidyl Peptidase IV/CD26 inhibited with Diisopropyl FluoroPhosphate
    1tkr: Human Dipeptidyl Peptidase IV/CD26 inhibited with Diisopropyl FluoroPhosphate
  • 1u8e: HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F
    1u8e: HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F
  • 1w1i: CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE
    1w1i: CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE
  • 1wcy: Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Diprotin A
    1wcy: Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Diprotin A
  • 1x70: HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR
    1x70: HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR
  • 2ajl: X-ray Structure of Novel Biaryl-Based Dipeptidyl peptidase IV inhibitor
    2ajl: X-ray Structure of Novel Biaryl-Based Dipeptidyl peptidase IV inhibitor
  • 2bgn: HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT (1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)
    2bgn: HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT (1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)
  • 2bgr: CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)
    2bgr: CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)
  • 2bub: CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH A REVERSED AMIDE INHIBITOR
    2bub: CRYSTAL STRUCTURE OF HUMAN DIPEPTIDYL PEPTIDASE IV (CD26) IN COMPLEX WITH A REVERSED AMIDE INHIBITOR
  • 2fjp: Human dipeptidyl peptidase IV/CD26 in complex with an inhibitor
    2fjp: Human dipeptidyl peptidase IV/CD26 in complex with an inhibitor
  • 2g5p: Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 21ac
    2g5p: Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 21ac
  • 2g5t: Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 21ag
    2g5t: Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 21ag
  • 2g63: Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 24b
    2g63: Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 24b
  • 2hha: The structure of DPP4 in complex with an oxadiazole inhibitor
    2hha: The structure of DPP4 in complex with an oxadiazole inhibitor
  • 2i03: Crystal structure of human dipeptidyl peptidase 4 (DPP IV) with potent alkynyl cyanopyrrolidine (ABT-279)
    2i03: Crystal structure of human dipeptidyl peptidase 4 (DPP IV) with potent alkynyl cyanopyrrolidine (ABT-279)
  • 2iit: Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
    2iit: Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
  • 2iiv: Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
    2iiv: Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor
  • 2ogz: Crystal structure of DPP-IV complexed with Lilly aryl ketone inhibitor
    2ogz: Crystal structure of DPP-IV complexed with Lilly aryl ketone inhibitor
  • 2oph: Human dipeptidyl peptidase IV in complex with an alpha amino acid inhibitor
    2oph: Human dipeptidyl peptidase IV in complex with an alpha amino acid inhibitor
  • 2oqi: Human Dipeptidyl Peptidase IV (DPP4) with Piperidinone-constrained phenethylamine
    2oqi: Human Dipeptidyl Peptidase IV (DPP4) with Piperidinone-constrained phenethylamine
  • 2oqv: Human Dipeptidyl Peptidase IV (DPP4) with piperidine-constrained phenethylamine
    2oqv: Human Dipeptidyl Peptidase IV (DPP4) with piperidine-constrained phenethylamine
  • 2p8s: Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor
    2p8s: Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor
  • v
  • t
  • e
1–50
51–100
101–150
151–200
201–250
251–300
301–350
  • v
  • t
  • e
3.4.11-19: Exopeptidase
3.4.11
3.4.13
3.4.14
3.4.15
3.4.16
3.4.17
Other/ungrouped
3.4.21-25: Endopeptidase
3.4.99: Unknown
Portal:
  • icon Biology